Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Tuberculosis (TB) remains a serious global health threat and an improved vaccine is urgently needed. New candidate TB vaccines are tested using preclinical animal models such as mice, guinea pigs, cattle and non-human primates. Animals are routinely infected with virulent Mycobacterium tuberculos...

Полное описание

Библиографические подробности
Главные авторы:	Tanner, R, McShane, H
Формат:	Journal article
Опубликовано:	ALTEX Edition 2016

Схожие документы

Vaccines for tuberculosis
по: McShane, H
Опубликовано: (2013)

Reducing, refining and replacing the use of animals in toxicity testing /
по: Allen, David G. (David Glenwood), и др.
Опубликовано: (2014)

Vaccine strategies against tuberculosis
по: H McShane
Опубликовано: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
по: McShane, H
Опубликовано: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
по: McShane, H
Опубликовано: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
по: McShane, H
Опубликовано: (2011)

Tuberculosis vaccines: Progress and challenges
по: Checkley, A, и др.
Опубликовано: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
по: McShane, H
Опубликовано: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
по: Davenne, T, и др.
Опубликовано: (2016)

Editorial: 3Rs approach (replace, reduce and refine animal models) to improve preclinical research
по: Laura Calvillo
Опубликовано: (2022-10-01)

Clinical testing of tuberculosis vaccine candidates
по: Hatherill, M, и др.
Опубликовано: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
по: Vermaak, S, и др.
Опубликовано: (2023)

A Novel Dental Caries Model Replacing, Refining, and Reducing Animal Sacrifice
по: Amit Wolfoviz-Zilberman, и др.
Опубликовано: (2021-08-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
по: Hopkins, R, и др.
Опубликовано: (2011)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
по: Dockrell, HM, и др.
Опубликовано: (2022)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
по: Hayward, S, и др.
Опубликовано: (2018)

Human and Bovine Tuberculosis
по: McShane, H
Опубликовано: (2016)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
по: Stylianou, E, и др.
Опубликовано: (2019)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
по: McShane, H, и др.
Опубликовано: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
по: McShane, H, и др.
Опубликовано: (2014)

Vaccination against tuberculosis: how can we better BCG?
по: Pitt, J, и др.
Опубликовано: (2013)

Vaccination against tuberculosis: How can we better BCG?
по: Pitt, J, и др.
Опубликовано: (2013)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
по: Hazel M. Dockrell, и др.
Опубликовано: (2022-05-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
по: Mcshane, H, и др.
Опубликовано: (2016)

The humoral immune response to BCG vaccination
по: Tanner, R, и др.
Опубликовано: (2019)

Survey of Canadian animal-based researchers' views on the Three Rs: replacement, reduction and refinement.
по: Nicole Fenwick, и др.
Опубликовано: (2011-01-01)

Vaccine strategies against tuberculosis.
по: Mcshane, H
Опубликовано: (2009)

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.
по: Bethny Morrissey, и др.
Опубликовано: (2017-01-01)

Tuberculosis vaccines in clinical trials.
по: Rowland, R, и др.
Опубликовано: (2011)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
по: Richard Hopkins, и др.
Опубликовано: (2011-01-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
по: McShane, H
Опубликовано: (2020)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
по: Ota, M, и др.
Опубликовано: (2011)

Local pulmonary immunological biomarkers in tuberculosis
по: Morrison, H, и др.
Опубликовано: (2021)

Developing an improved vaccine against tuberculosis.
по: Mcshane, H
Опубликовано: (2004)

Tuberculosis vaccines: progress and challenges.
по: Checkley, A, и др.
Опубликовано: (2011)

Tuberculosis vaccines: present and future.
по: Minassian, A, и др.
Опубликовано: (2008)

Challenges in developing a controlled human tuberculosis challenge model
по: Jackson, S, и др.
Опубликовано: (2022)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
по: Mcshane, H, и др.
Опубликовано: (2017)

Refinement of Animal Experiments: Replacing Traumatic Methods of Laboratory Animal Marking with Non-Invasive Alternatives
по: Ilya Klabukov, и др.
Опубликовано: (2023-11-01)

Refinements to Animal Models for Biomedical Research
по: Gabrielle C. Musk
Опубликовано: (2020-12-01)